Cigna's ACA Retreat, Nebraska's Medicaid First, and a Q1 That Rewarded Discipline Over Growth

The week of April 27 through May 3 produced a paradox that will define the rest of 2026 for the U.S. health insurance industry. On the same days that the country's largest carriers reported first-quarter results showing the strongest margin discipline in two years, two of those carriers were quietly walking away from the individual market that the Affordable Care Act spent a decade trying to stabilize. Cigna's announcement on Thursday, April 30 that it will exit the ACA exchanges at the end of 2026 — stranding 369,000 members across 11 states — landed in the same earnings release that disclosed a $1.65 billion quarterly profit. A day later, Nebraska became the first state in the country to actually turn on Medicaid work requirements under last summer's One Big Beautiful Bill Act, putting tens of thousands of expansion enrollees on a compliance clock that ends in coverage loss. The two stories are not unrelated. Both reflect a payer industry that has decided, after 18 months of cost shock, that selectivity is more profitable than scale, and a federal-state policy environment that is increasingly happy to oblige.

A Profitable Retreat From the Individual Market

Cigna's exit was the most consequential carrier news of the week and the cleanest illustration of the new posture. Speaking on the company's Thursday earnings call, Chief Operating Officer Brian Evanko told analysts that Cigna had concluded there was no "clear path" to scale its ACA business into a meaningful operation, and that the capital and management attention currently consumed by the individual line would be redirected to Evernorth specialty and care services, the pharmacy benefit manager, and employer-sponsored coverage — the segments Cigna views as core to its future. The company's individual exchange enrollment had already fallen 17 percent in the first quarter, dropping from 446,000 members in Q1 2025 to 369,000 in Q1 2026, even as Cigna expanded its geographic footprint into 20 additional counties for the open enrollment that closed in January. The states losing Cigna at the end of this plan year are Arizona, Colorado, Florida, Georgia, Illinois, Indiana, Mississippi, North Carolina, Tennessee, Texas, and Virginia — a footprint that includes three of the four largest ACA marketplaces in the country.

The exit lands less than a year after CVS Health's Aetna left the ACA market entirely at the start of 2026, displacing roughly one million enrollees across 17 states. Two of the five largest publicly traded health insurers have now decided, in the span of 12 months, that the individual exchange is not a market they want to be in. Cigna's enrollment loss is likely an undercount of the total disruption: roughly half of the 369,000 affected members live in Texas, Florida, and Georgia — three non-expansion states where the ACA marketplace is the only realistic on-ramp to subsidized coverage for working-age adults — and the exit will force them to re-shop during the November 2026 open enrollment window even as the enhanced premium tax credits that have anchored marketplace affordability since 2021 are already scheduled to lapse. Peterson-KFF data from earlier in April showed the median ACA insurer requesting an 18 percent premium increase for 2027, eleven percentage points higher than the prior cycle, citing the loss of enhanced subsidies as a primary driver. Cigna leaving 11 states removes a competitive option for re-pricing in markets where, as one analyst put it, "the only thing keeping the curve from going vertical is the fact that BCBS plans still have a reason to participate."

What made the timing remarkable was the financial backdrop. Cigna's Q1 net income jumped sharply on the strength of Express Scripts and Evernorth, and the company reaffirmed full-year guidance even as it announced the ACA wind-down. There was no medical-cost emergency, no acute loss line. The decision was a strategic one: Cigna concluded that the individual market does not earn its keep. That framing — articulated almost word-for-word by Evanko — is the framing every other commercial carrier with a marginal exchange book is going to be asked to justify between now and the August 2026 rate filing deadline.

A Q1 Earnings Cycle That Rewarded Discipline

If the ACA story was the week's most damaging headline, the underlying Q1 earnings cycle explained why payers feel comfortable making it. The numbers landed during a tight three-day window, with Centene reporting on Tuesday, April 28, Humana on Wednesday, April 29, and Cigna and CVS finishing the cycle that Thursday and the following week. Across the board the results showed the same pattern: medical loss ratios coming in materially below analyst expectations, guidance moving up, and management teams talking about reserves and pricing discipline rather than membership growth.

Centene set the tone on Tuesday. The company posted Q1 adjusted diluted EPS of $3.37, beating consensus by roughly 50 cents, on premium and service revenues that beat a Street already trying to recalibrate after the carrier comeback narrative had taken hold the previous week. The company's consolidated health benefits ratio was 87.3 percent, down slightly from 87.5 percent a year earlier, with Medicaid landing at 93.1 percent — described by management as evidence of "tangible progress managing medical costs coupled with moderate flu" — and Medicare clocking in at 84.9 percent on outperformance in both Medicare Advantage and the standalone Part D book. The commercial HBR was 75.3 percent, slightly above expectations because of higher acuity among Marketplace Silver Tier members that management said would be partly offset by a future risk-adjustment benefit. Centene raised its 2026 premium and service revenues guidance by $1 billion to a range of $171 billion to $175 billion, drove the floor on adjusted EPS up to greater than $3.40, and made clear that the Medicaid book remains the engine. The shift in tone from one quarter ago — when Centene was the carrier most associated with the cost shock that battered the industry through 2025 — was striking.

Humana followed on Wednesday with a quarter that satisfied investors looking for evidence the Medicare Advantage trade is repairable. Adjusted EPS came in at $10.31 on revenue of $39.65 billion, up 23 percent year over year, and the company affirmed its full-year individual MA membership growth target of approximately 25 percent over 2025. Year-to-date individual MA growth was already running at 22 percent, with about 1,144,000 members added since the start of the year — the kind of number that, under different circumstances, would put Humana on track to overtake UnitedHealthcare as the largest MA insurer in the country. The Q1 Insurance segment GAAP benefit ratio came in at 89.4 percent, slightly favorable to management's guidance of just under 90, and CEO Jim Rechtin used the call to walk analysts through the company's 2027 bid strategy. Net income did fall to $1.19 billion as lower star ratings reduced federal bonus payments and Humana trimmed GAAP EPS guidance to at least $8.36, but the company reaffirmed adjusted EPS of at least $9 and an Insurance benefit ratio of 92.75 percent plus or minus 25 basis points. Humana also disclosed that George Renaudin, president of the Insurance segment, will retire effective June 29, with Aaron Martin — currently president of Medicare Advantage — taking over the segment as Renaudin moves into a strategic advisor role. The leadership change places the architect of Humana's MA growth turn directly in charge of the segment ahead of the 2027 bid cycle.

Cigna's Thursday results, beyond the ACA exit, showed the pattern again: roughly $1.65 billion in net income, the Evernorth and Express Scripts engines compounding, and a 2026 guide that was reaffirmed rather than raised because the company had already taken the hit on individual exchange. CVS Health, reporting at the start of the following week, completed the picture: Q1 revenue of $100.4 billion, adjusted EPS of $2.57, and an Aetna medical loss ratio of 84.6 percent against a Street estimate of 87.58 — nearly three full points of MLR cushion that translated into a guidance raise to a 2026 adjusted EPS range of $7.30 to $7.50 and full-year revenue of at least $405 billion. The five-quarter beat streak at CVS now reads less like a recovery and more like a regime change.

The synthesis from the analyst community was almost uniform. As CNBC's wrap of the week put it, results were "largely expected" given seasonal factors — a milder flu season and weather disruptions that suppressed elective utilization — but every carrier had also strengthened medical reserves, building cushion that supports a more confident 2026 outlook. The risk, several sell-side analysts wrote, is that 2026 has now become the easy compare. The harder question is what happens when those reserves have to cover whatever the market actually delivers in the back half of the year, including the impact of the very ACA disruption that two of the same carriers just helped accelerate.

Nebraska Pulls the Trigger on Work Requirements

While the carrier Q1 cycle was unfolding, the most consequential public-program story was happening 1,200 miles west of Wall Street. On Friday, May 1, Nebraska became the first state in the country to actually implement Medicaid work requirements under H.R. 1, the One Big Beautiful Bill Act that passed last July. Governor Jim Pillen and CMS Administrator Mehmet Oz had announced the state's pursuit of the requirement back in February, but May 1 was when it stopped being a press release and started being a coverage rule. Members and applicants eligible under Medicaid expansion — able-bodied adults ages 19 through 64 who are not otherwise exempt — must now spend at least 80 hours in a calendar month working, attending school or an apprenticeship at least half time, performing community service, or participating in a state-approved employment program. The threshold can also be met by earning $580 in a calendar month, equivalent to 80 hours at the federal minimum wage.

The implementation design is more aggressive than what most policy analysts had projected. The Center on Budget and Policy Priorities, which has been tracking state preparation under H.R. 1, described Nebraska as "launching punitive Medicaid work requirements early, even as states lack information and time" — pointing to the fact that federal guidance from CMS has not yet caught up with the implementation timelines a number of states are now adopting. KFF's pre-launch analysis estimated that tens of thousands of Nebraska expansion enrollees could lose coverage during the first year. The state has built in a partial runway: members with renewal dates in May or June 2026 will not have to demonstrate compliance until their 2027 renewals, and existing enrollees more broadly will not be checked against the requirement until their next redetermination, which the state expects to begin running on July 31. But for new applicants, May 1 was a hard switch.

For brokers, employers, and self-funded plans, the Nebraska launch matters for reasons that go well beyond the state's borders. Forty other states have either filed or signaled intent to file Section 1115 work requirement waivers under the H.R. 1 framework, and Nebraska is now the operational template. The compliance infrastructure the state has stood up — the 80-hour calendar-month rule, the $580 earnings equivalent, the renewal-aligned check schedule — will be studied, copied, and litigated by every state Medicaid agency in the country. It will also be the first real test of whether the carrier Medicaid books that drove Centene's Q1 beat can absorb the membership churn that work requirements historically produce. Arkansas's 2018 work requirement experiment, the only previous state implementation, removed 18,000 enrollees from the rolls before a federal court enjoined it. The Nebraska version is more carefully designed to survive judicial review, but the membership and acuity dynamics it creates are almost identical.

What the Week Means in Practice

Three throughlines connected the week's stories that brokers and benefits leaders should keep in view as the rest of 2026 unfolds. The first is that the individual market is now structurally smaller and more BCBS-dependent than it was 18 months ago, and the carriers exiting are the ones with the most diversified non-individual books. The second is that Medicare Advantage growth has not gone away — Humana's 22 percent year-to-date growth proves it — but it has become explicitly margin-disciplined, with carriers willing to shed members rather than chase low-margin enrollment. The third is that the One Big Beautiful Bill Act is no longer hypothetical: as of Friday, it is operating policy in at least one state, and the implementation choices Nebraska just locked in will shape every other state's program design.

The numbers most likely to matter through the summer rate-filing season can be summarized briefly:

• Cigna ACA footprint loss for 2027: 369,000 members across 11 states (Arizona, Colorado, Florida, Georgia, Illinois, Indiana, Mississippi, North Carolina, Tennessee, Texas, Virginia)
• Combined Cigna + Aetna ACA exit impact since Jan 2026: roughly 1.37 million displaced enrollees
• Nebraska Medicaid work requirement effective date: May 1, 2026, with renewal-based compliance checks beginning July 31

The broader context, captured in the same week's employer-side data, is that none of this is happening in isolation. Mercer's running analysis of 2026 health benefit costs continues to show the largest per-employee increase since 2010 — a 6.5 percent rise that pushes average employer cost per employee past $17,000 for the first time, with GLP-1 spending now accounting for roughly 20 percent of total prescription drug costs and 77 percent of large employers ranking GLP-1 cost management as extremely or very important. A Bloomberg feature published April 29 documented that the strain has begun to push young, healthy professionals out of employer-sponsored coverage altogether, choosing to go uninsured or to seek cheaper individual market alternatives at exactly the moment those alternatives are being withdrawn.

The carriers reporting this week are not blind to that dynamic. Cigna's executives explicitly cited the long-term value of redirecting capital toward Evernorth and pharmacy benefits — segments that capture revenue from employer plans regardless of which way enrollment moves. The Q1 earnings cycle, in other words, told a coherent story: the most profitable health insurance business in 2026 is no longer the business of insuring the most lives. It is the business of being selective about which lives, in which markets, on which contracts. Cigna's ACA exit and Nebraska's work requirement launch are, in different registers, the same announcement. The week of April 27 was when the rest of the industry began to absorb what that means.